PMA supplement
P900056 S216: Rotablator and ROTAPRO Rotational Atherectomy System
FDA PMA supplement · 30-Day Notice · Boston Scientific Corp
Key facts
| Original PMA | P900056 |
|---|---|
| Supplement number | S216 |
| Supplement type | 30-Day Notice |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | Rotablator and ROTAPRO Rotational Atherectomy System |
| Generic name | CATHETER, CORONARY, ATHERECTOMY |
| Applicant | Boston Scientific Corp |
| Product code | MCX |
| Received date | Feb 16, 2024 |
| Decision date | Mar 15, 2024 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: